Grazoprevir Sd
Generic Name: grazoprevir sd
Dosage form: POWDER. Active ingredients: GRAZOPREVIR (30 kg/100kg). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: POWDER. Active ingredients: GRAZOPREVIR (30 kg/100kg). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as powder.
Related Medications
Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Calcarea Sulphurica, Calcarea Fluorica, Calcarea Phosphorica, Ferrum Phosphoricum, Magnesia Phosphorica, Silicea
kali muriaticum, kali phosphoricum, kali sulphuricum, natrum muriaticum, natrum phosphoricum, natrum sulphuricum, calcarea sulphurica, calcarea fluorica, calcarea phosphorica, ferrum phosphoricum, magnesia phosphorica, silicea
INDICATIONS: May temporarily relieve symptoms of impaired cellular function, such as constant thirst.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Aminosalicylic Acid Resin Complex
aminosalicylic acid resin complex
Manufactured by BRISTOL MYERS SQUIBB. Dosage form: POWDER. Route: ORAL. Active ingredients: AMINOSALICYLIC ACID RESIN COMPLEX (EQ 500MG BASE/GM). Application: NDA009052.
Zolbetuximab
zolbetuximab
Claudin 18.2-directed Cytolytic Antibody [EPC]
11 DESCRIPTION Zolbetuximab-clzb is a chimeric (mouse/human) antibody composed of variable regions derived from mouse anti-human claudin-18 isoform 2 monoclonal antibody and constant regions derived from human IgG1. The molecular weight is approximately 147 kDa. VYLOY (zolbetuximab-clzb) for injection is provided as a sterile, preservative-free, white to off-white lyophilized powder in single-dose vials for intravenous use.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.